WCN24-1146 SAFETY AND EFFICACY OF IPTACOPAN IN ADOLESCENT PATIENTS WITH IDIOPATHIC (PRIMARY) IMMUNE-COMPLEX-MEDIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)

Abstract

Open access

Peer reviewed

Nicholas Webb, David Kavanagh, Andrew S. Bomback, Richard J.H. Smith, UdayKiran Veldandi, Yaqin Wang, Matthias Meier and Marina Vivarelli

Kidney international reports, Vol.9(4 Supplement), pp.S116-S117

04/2024

DOI: 10.1016/j.ekir.2024.02.240

Files and links (1)

url

https://doi.org/10.1016/j.ekir.2024.02.240View

Published (Version of record) Open Access

Title: Subtitle: WCN24-1146 SAFETY AND EFFICACY OF IPTACOPAN IN ADOLESCENT PATIENTS WITH IDIOPATHIC (PRIMARY) IMMUNE-COMPLEX-MEDIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)
Creators: Nicholas Webb - Basel, Global Drug Development, Switzerland
David Kavanagh - Newcastle upon Tyne Hospitals NHS Foundation Trust
Andrew S. Bomback - Columbia University
Richard J.H. Smith - University of Iowa
UdayKiran Veldandi - Global Drug Development, Novartis HC Pvt Ltd, Hyderabad
Yaqin Wang - Global Drug Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ
Matthias Meier - Novartis (Netherlands)
Marina Vivarelli - Bambino Gesù Children's Hospital
Resource Type: Abstract
Publication Details: Kidney international reports, Vol.9(4 Supplement), pp.S116-S117
DOI: 10.1016/j.ekir.2024.02.240
ISSN: 2468-0249
eISSN: 2468-0249
Publisher: Elsevier Inc
Language: English
Date published: 04/2024
Academic Unit: Roy J. Carver Department of Biomedical Engineering; Molecular Physiology and Biophysics; Anatomy and Cell Biology; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Otolaryngology; Internal Medicine
Record Identifier: 9984577110802771

9 Record Views